masoprocol has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardal, T; Bjerve, KS; Brekke, OL; Espevik, T | 1 |
| Kohgo, Y | 1 |
2 other study(ies) available for masoprocol and EHS Tumor
| Article | Year |
|---|---|
Effects of n-3 and n-6 fatty acids on tumor necrosis factor cytotoxicity in WEHI fibrosarcoma cells.
Topics: Animals; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Cell Survival; Clone Cells; Dexamethasone; Fatty Acids, Nonesterified; Fatty Acids, Unsaturated; Fibrosarcoma; Indomethacin; Kinetics; Lipid Metabolism; Masoprocol; Mice; Phospholipids; Sarcoma, Experimental; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 1992 |
[Transfer of interleukin 2-activated lymphocytes].
Topics: Adult; Aged; Animals; Dimethyl Sulfoxide; Ethanol; Female; Fibrosarcoma; Humans; Immunization, Passive; Interleukin-2; Killer Cells, Natural; Lymphocyte Activation; Male; Masoprocol; Mice; Mice, Inbred BALB C; Middle Aged; Neoplasms; Sarcoma, Experimental | 1987 |